Skip to main content
Premium Trial:

Request an Annual Quote

Genome Institute of Singapore Buys Three Sequenom MassArrays

NEW YORK (GenomeWeb News) — The Genome Institute of Singapore has purchased two of Sequenom’s MassArray systems and will use them with the company’s iPLEX Gold genotyping assay, Sequenom said today.
 
The institute also will use Sequenom’s EpiTYPER epigenetic assay, used to study DNA methylation for cancer research.
 
GIS senior investigator Edison Liu said the institute will use the tools in its studies of population genetics, fine mapping analysis, and breast cancer. 
 
Financial terms of the deal were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more